Oral I.1, Stejskal D.2, Loucký J.3, Šišlák Z.1, Coufal Z.1, Mistrík J.1, Náplava R.1:
An Impact of
an Acute Fluid Restriction on Levels of Natriuretic Peptides in Patients on Chronic Dialysis
Program
|
812 |
Perušičová J.1, Haas T.2:
Rosiglitazon in Treatment of Type II Diabetes Mellitus - Experience
of Diabetologists in the Czech Republic. Part I: Compensation of Diabetes, Sugar Metabolism
|
818 |
Payer J.1, Hainer V.2, Ondrejka P.3, Kajtor Z.4:
Sibutramin in Obesity Treatment (Multicentric,
Opened, Prospective 12-Month-Long Study)
|
825 |
Lata J.1, Juránková J.2, Husová L.1, Šenkyřík M.1, Dítě P.1, Dastych M.3, Příbramská V.1:
Factors Participating in Development of Bleeding Varices in Portál Hypertension. Part I: Bacterial Infection and Comparison of Intravenous and Peroral Antibiotics Effects - A Randomised Study
|
830 |
Hofírek I.1, Sochor O.1, Olšovský J.2:
Assessment of Changes in Peripheral Microcirculation
in Type I Diabetics with Laser Doppler Flowmetry
|
836 |
Wenchich L.1, Krechler T.2, Švestka T.2, Horák J.3, Šedivá A.4, Bartůňková J.4, Hansíková H.1, Martásek P.1, Zeman J.1:
Primary Biliary Cirrhosis - Specific Anti-mitochondrial Antibodies
|
842 |
Paleček T., Lubanda J.-C., Magage S., Karetová D., Bultas J., Linhart A.:
Cardiac Manifestation
of Fabry’s Disease: Current Knowledge
|
846 |
Dvořáková A., Poledne R.:
High-sensitivity C-reactive protein - New Parameter in Cardiovascular
Risk Assessment
|
852 |
Fialová P., Vlček J.:
The Role of Anti-Ulcerative Drugs in Treatment and Prevention of Gastropathies
Induced by Nonsteroidal Anti-Inflammatory Drugs
|
858 |
Kojecký V.:
Diabetic Gastroparesis and Gastropathy
|
867 |
Praus R.1, Pařízek P.1, Červinka P.1, Haman L.1, Tauchman M.2, Šťásek J.1, Pudil R.1, Gregor J.1, Hudík M.3, Hodač M.1:
Syncope in Ventricular Tachycardia as a First Clinical Sign of Patent
Ductus Arteriosus in an Adulthood
|
873 |
